
Novo Nordisk cuts some US supply of obesity drug Wegovy to cope with demand
Novo Nordisk cuts some US supply of obesity drug Wegovy to cope with demand By Nikolaj Skydsgaard CO...
4th May, 2023

Novo Nordisk cuts some US supply of obesity drug Wegovy to cope with demand By Nikolaj Skydsgaard CO...
4th May, 2023

GSK bets $2 billion on Bellus cough drug to soothe pipeline fears By Natalie Grover and Aby Jose Koi...
18th April, 2023

Agnellis’ Exor eyes further healthcare investment for expansion By Giulio Piovaccari MILAN (Reuters)...
17th April, 2023

LONDON (Reuters) – Britain’s health minister warned patients’ safety is at risk as junior doctors be...
11th April, 2023

Healthcare R&D spending in the United States increased by more than 33% between 2018 and 2020. Sever...
13th March, 2023

Manufacturers are increasing their presence across emerging markets and forging effective distributi...
13th March, 2023

Fewer reimbursement policies have been a major factor in the decline of BPS in the atopic dermatitis...
13th March, 2023

By Maggie Fick LONDON (Reuters) -GSK expects to launch its respiratory syncytial virus (RSV) vaccine...
9th March, 2023

China has the largest market share for protective clothing market and is expected a CAGR value growt...
8th March, 2023

The USA has emerged as one of the most lucrative markets for intelligent pill bottles and boxes, and...
8th March, 2023

A significant market for self-testing products is the United Kingdom. with a strong healthcare syste...
8th March, 2023

North America is expected to account for about 25.4% of the global microfluidics market. The high fr...
8th March, 2023